COMP <GO>
CELU vs BCTX // GROSS PROFIT MARGIN
Celularity Inc. (Class A) (NASDAQ) VS. BriaCell Therapeutics Corp. (NASDAQ) • 15-METRIC TALLY: CELU 1
— BCTX 1
■ METRIC PARITY
LAST: $0.80 (+0.30%) • MKT CAP: $26.0M
gross-margins
24.40%
LAST: $3.09 (+1.65%) • MKT CAP: $26.5M
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CELU VS. BCTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CELU | BCTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 24.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -51.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 1/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.9 | 35.7 | +1.20 | CELU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $26.0M | $26.5M | -$582.6K | BCTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CELU REV | BCTX REV | CELU GROSS % | BCTX GROSS % | CELU FCF | BCTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $26.6M | $76.2M | 24.4% | — | -$13.3M | -$28.2M |
| FY 2024 | $54.2M | $93.3M | 72.4% | — | -$6.6M | -$24.6M |
| FY 2023 | $22.8M | $65.2M | — | — | -$38.7M | -$23.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CELU // BETA —
BCTX // BETA —